Patent Assignment
Reel/Frame 070702/0530
Assignment of Assignor's Interest
Recorded: 2025-04-01
Pages: 5
Assignor
HEITZMANN, MARKUS
Executed: 2015-03-16
Assignee
NOVARTIS PHARMA AG
POSTFACH, BASEL, 4002, SWITZERLAND
Covered Property
(1)
Selective Reduction of Cysteine Residues in Il-17 Antibodies
Application:
19/065,656 →
Publication:
US US20260116964A1
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 1, 2025
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 070702/0572 →
Assignment of Assignor's Interest
Apr 2, 2025
From: WINKLER, JOHANN
To: SANDOZ GMBH
Reel/Frame 070703/0482 →
Assignment of Assignor's Interest
Apr 2, 2025
From: SANDOZ GMBH
To: SANDOZ AG
Reel/Frame 070703/0495 →
Assignment of Assignor's Interest
Apr 2, 2025
From: SANDOZ AG
To: NOVARTIS AG
Reel/Frame 070703/0499 →
Assignment of Assignor's Interest
Jun 11, 2026
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 075712/0291 →